Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2011
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia AU Martinowitz, J Bjerre, B Brand, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 1, 2018
Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary dataD Schopohl, C Bidlingmaier, D Herzig, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2014
The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia AV Jiménez-Yuste, S Lejniece, R Klamroth, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2016
How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general populationK Berger, D Schopohl, G Lowe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Management of bleeding disorders in adultsF Peyvandi, R Klamroth, M Carcao, et al.
Hamostaseologie|November 2, 2012
[Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis]J Koscielny, J Beyer-Westendorf, C von Heymann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 31, 2008
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophiliaA Rentz, E Flood, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2009
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendationsC Hermans, C Altisent, A Batorova, et al.
Pageof 5